# Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

> **NCT00621634** · PHASE2 · WITHDRAWN · sponsor: **Université de Montréal**

## Conditions studied

- Tardive Dyskinesia

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 fish oil capsules (including DHA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00621634
- **Lead sponsor:** Université de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-02
- **Primary completion:** 2010-02-01
- **Final completion:** 2010-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study products withdrawn from market.
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621634, "Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00621634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*